DexCom (NASDAQ:DXCM) PT Raised to $151.00
DexCom (NASDAQ:DXCM – Get Free Report) had its target price raised by equities research analysts at Raymond James from $147.00 to $151.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ target price would indicate a potential upside of 18.51% […]
More Stories
Ostin Technology Group Co., Ltd. (NASDAQ:OST) Short Interest Down 18.0% in December
Ostin Technology Group Co., Ltd. (NASDAQ:OST – Get Free Report) was the target of a significant drop in short interest...
Baker Hughes (BKR) – Investment Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Baker Hughes (NASDAQ: BKR) in the last few...
Azincourt Energy (CVE:AAZ) Shares Down 33.3% – What’s Next?
Azincourt Energy Corp. (CVE:AAZ – Get Free Report)’s stock price dropped 33.3% on Tuesday . The company traded as low...
UnitedHealth Group Incorporated (NYSE:UNH) Short Interest Update
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) saw a large drop in short interest during the month of December....
Topline Capital Management, Ll Sells 13,674 Shares of Optex Systems Holdings, Inc (NASDAQ:OPXS) Stock
Optex Systems Holdings, Inc (NASDAQ:OPXS – Get Free Report) insider Topline Capital Management, Ll sold 13,674 shares of the stock...
Insider Selling: Green Dot Co. (NYSE:GDOT) Insider Sells 380,611 Shares of Stock
Green Dot Co. (NYSE:GDOT – Get Free Report) insider Topline Capital Management, Ll sold 380,611 shares of the company’s stock...